[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2021209269A1 - A process for preparation of substituted enamine compounds - Google Patents

A process for preparation of substituted enamine compounds Download PDF

Info

Publication number
WO2021209269A1
WO2021209269A1 PCT/EP2021/058580 EP2021058580W WO2021209269A1 WO 2021209269 A1 WO2021209269 A1 WO 2021209269A1 EP 2021058580 W EP2021058580 W EP 2021058580W WO 2021209269 A1 WO2021209269 A1 WO 2021209269A1
Authority
WO
WIPO (PCT)
Prior art keywords
acid
compound
formula
methyl
ethyl
Prior art date
Application number
PCT/EP2021/058580
Other languages
French (fr)
Inventor
Werner Bonrath
Le DAI
Xixiang DAI
Qiangqiang LIU
Marc-André Mueller
Kun Peng
Liuhai WU
Lei Zhang
Zili Zhang
Original Assignee
Dsm Ip Assets B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets B.V. filed Critical Dsm Ip Assets B.V.
Priority to EP21717374.9A priority Critical patent/EP4136066A1/en
Priority to CN202180027529.0A priority patent/CN115397807B/en
Publication of WO2021209269A1 publication Critical patent/WO2021209269A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/30Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups

Definitions

  • the present invention is related to a new process for producing substituted enamine compounds.
  • Oxazole compounds represent a vast class of heterocyclic aromatic organic compounds. Oxazole compounds have become increasingly important because of biological activities and their use as intermediates for the preparation of new biological materials.
  • the wide range of biological activities of oxazole compounds includes anti-inflammatory, analgesic, antibacterial, antifungal, hypoglycemic, antiproliferative, anti-tuberculosis, muscle relaxant and HIV inhibitor activity.
  • oxazole derivatives are important intermediates for preparation of biological compounds such as vitamin B 6 .
  • oxazole compounds Various processes for the preparation of oxazole compounds have been developed.
  • One preferred process in industry is from alanine and oxalic acid in EtOH carried out by azeotropic distillation with benzene.
  • the ring closure reaction to obtain 5-ethoxy-4-methyloxazole can also be carried out using phosgene or triphosgene, which is toxic and not environment friendly (see CN 104725262 B, CN 102898321 A and CN 105985297 A)
  • the present invention provides a substituted enamine compound of formula (I), which can be converted to an oxazole compound, wherein R is H, lower alkyl or aryl, optionally substituted by one or more substituents.
  • the present invention also provides a process for producing the compound of formula (I) and a process for producing oxazole compounds from the compound of formula (I).
  • the term "lower alkyl” as used refers to Ci-Cio alkyl, i.e., branched or unbranched, cyclic or non-cyclic, saturated hydrocarbon comprising 1-10 carbon atoms.
  • the "lower alkyl” is Ci-C 6 alkyl, including but not limited to methyl, ethyl, propyl, isopropyl, cyclopropyl, butyl, isobutyl, tert- butyl, cyclobutyl, pentyl, iso-pentyl, tert-pentyl, cyclopentyl, hexyl, isohexyl, tert-hexyl, cyclohexyl, octyl, isooctyl, tert-octyl, cyclooctyl, nonyl, isononyl, tert-nonyl, cyclon
  • aryl refers to aromatic hydrocarbon such as phenyl, benzyl, xylyl and naphthalenyl.
  • lower alkoxyl refers to the structure represented by (lower alkyl)-0-, wherein the lower alkyl is defined as above.
  • halo or halogen refers to a group of elements including fluorine (F), chlorine (Cl), bromine (Br) and iodine (I), preferably refers to Cl or Br.
  • substituted refers to lower alkyl, lower alkoxyl, hydroxyl, halo, -NH 2 , -N0 2 , cyano or isocyano.
  • the present invention provides a process for producing a compound of formula (I), comprising: a) reacting a compound of formula (II) with a compound of formula (III) to produce a compound of formula (la); and b) converting the compound of formula (la) into the compound of formula (I),
  • R is H, lower alkyl or aryl, optionally substituted by one or more substituents
  • R' is H; and any two of Ri, R 2 and R 3 , together with the carbon they connect, form a carbonyl group, and the rest one is hydroxyl, lower alkyl, lower alkoxyl, aryl, or NR 4 R 4 ' (wherein R 4 and R 4 ' are dependently H or lower alkyl), optionally substituted by one or more substituents; or R', Ri, R 2 and R 3 , together with the carbon they connect, form carbon monoxide (Co0).
  • R is H or Ci-Ce alkyl, optionally substituted by one or more substituents. More preferably, R is H, methyl, ethyl, propyl or butyl, optionally substituted by one or more substituents. The most preferably, R is H or methyl.
  • the rest one is hydroxyl, methyl, ethyl, propyl, butyl, methoxyl, ethoxyl, propoxyl, butoxyl, or NR 4 R 4 ' (wherein R and R ' are dependently H, methyl, ethyl, propyl or butyl), optionally substituted by one or more substituents.
  • the rest one is hydroxyl, methoxyl, ethoxyl, or NR 4 R 4 ' (wherein R and R ' are dependently H, methyl or ethyl), optionally substituted by one or more substituents.
  • R', Ri, R 2 and R 3 together with the carbon they connect, form carbon monoxide (Co0).
  • R is H, methyl, ethyl or phenyl; and any two of Ri, R 2 and R 3 , together with the carbon they connect, form a carbonyl group, and the rest one is hydroxyl, methoxyl, ethoxyl, or NR 4 R 4 ' (wherein R and R ' are dependently H, methyl or ethyl).
  • R is H, methyl, ethyl or phenyl
  • the compound of formula (III) is carbon monoxide.
  • R is H or methyl; and any two of Ri, R 2 and R 3 , together with the carbon they connect, form a carbonyl group, and the rest one is hydroxyl, methoxyl, ethoxyl, -NH 2 or -NHCH 3 .
  • the compound of formula (la) and (II) may be in a form of any salt of formula (la') and (IG) respectively:
  • X and Y are dependently a metal element such as alkali metal elements (lithium (Li), sodium (Na), postassium (K), rubidium (Rb), caesium (Cs) and francium (Fr)); or alkaline-earth metal elements (beryllium (Be), magnesium (Mg), calcium (Ca), strontium (Sr), barium (Ba) and radium (Ra)); and Iron (ll/lll), nickel and cobalt.
  • X is Na or K.
  • the compound of formula (III) may be added in an amount of from 0.01 moles to 20 moles, preferably from 0.05 moles to 15 moles, more preferably from 0.1 mole to 10 moles, per 1 mole of the compound of formula (II).
  • the step a) of the process of the present invention may be carried out in the presence of a solvent.
  • the solvent preferably is a polar organic solvent such as toluene, tetrahydrofuran (THF), methyl tert-butyl ether (TBME), alcohol (i.e., ethanol) and benzene, or mixture thereof.
  • the reaction of the step a) of the present invention may be carried out at the temperature from -30°C to 110°C, preferably from -20°C to 100°C, more preferably from -10°C to 50°C such as -10, -5, 0, 10, 15, 20, 25, 30, 35, 40, 45 and 50°C.
  • the obtained compound of formula (la) may be used to the next step b) directly or purified by known process such as crystallization and/or filtration.
  • the compound of formula (la) may be converted into the compound of formula (I) by any suitable way, for example, by adding water, an acid, an acidic salt or an alcohol.
  • the acid include but are not limited to organic acid such as formic acid, acetic acid, propionic acid, butyric acid, oxalic acid, citric acid, lactic acid, malic acid, succinic acid, tartaric acid, fumaric acid and maleic acid; inorganic acid such as hydrochloric acid, sulfonic acid, phosphoric acid, nitric acid, nitrous acid, chloric acid, hypochlorous acid, perchloric acid, sulfonic acid, hydrobromic acid and hydrofluoric acid; and acidic resin such as sulfonic acid resin.
  • the examples of the acidic salt include but are not limited to ammonium chloride, monopotassium phosphate, monosodium phosphate, sodium hydrogen sulfate and potassium hydrogen sulfate.
  • the examples of the alcohol include but are not limited to methanol, ethanol and phenol.
  • the compound of formula (la) is converted into the desired compound of formula (I) by adding an acid as defined above.
  • the acid may be added in an amount of from 0.1 mol to 10 mol, preferably from 0.5 mol to 8 mol, more preferably from 1 mol to 5 mol such as 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5 and 10 mol, per 1 mol of the compound of formula (la).
  • the compound of formula (la) is converted into the desired compound of formula (I) by adding water.
  • the water may be added in an amount of from 10 mL to 1000 mL, preferably from 18 mL to 500 mL, more preferably from 20 mL to 100 mL, per 1 mol of the compound of formula (la).
  • a solvent may be used when necessary.
  • suitable solvent include but are not limited to ethyl acetate, ethyl butyrate, butyl acetate, tetrahydrofuran, toluene, 1,4-dioxane, 2,5-dimethyltetrahydrofuran, methyl tetrahydrofuran, dimethyl ether, diethyl ether, acetonitrile, methyl tert-butyl ether, and mixture thereof.
  • the step b) of the process of the present invention may be carried out at the temperature from 0°C to 50°C, preferably from 10°C to 40°C, such as 10, 15, 20, 25, 30, 35 and 40°C.
  • the obtained compound of formula (I) may be directly used for industrial application, or purified by known process such as extraction, crystallization and/or filtration.
  • the reaction mixture of the step a) containing the compound of formula (la) is preferably used to the step b) directly without isolation and purification.
  • the process of the present application may be carried out in one pot.
  • the present invention also provides a one-pot process for the preparation of the compound of formula (I), which comprises adding the compound of formula (II) as defined above, the compound of formula (III) as defined above, optionally the solvent as defined above, and water or an acid or an acidic salt or an alcohol as defined above into one pot for reaction to obtain the compound of formula (I).
  • the compound of formula (II) may be prepared by any process known in the art in-situ or ex-situ, for example, by treating the compound of formula (lla) with a strong base such as sodium (Na), Sodium hydride (NaH) or sodium amide.
  • a strong base such as sodium (Na), Sodium hydride (NaH) or sodium amide.
  • the compounnd of formula (II) may be produced from nitriles as disclosed in US 5187297 A.
  • the processes of the present invention avoid toxic and unsafe reagents while providing high yield and high selectivity.
  • the obtained products of the processes of the present invention can be used for producing oxazole compounds directly without any purification.
  • the present invention provides a process for producing an oxazole compound comprising the step for producing the compound of formula (la) and/or the compound of formula (I) as described above.
  • the process of the present invention avoids toxic phosphate reagents and saves steps compared to the processes known in the art and thus provides a new process.
  • a dried four necked round bottom flask was charged with liquid ammonia (15 mL, 0.615 mol, 11 eq). After the flask was flushed with argon, sodium (1.5 g, 65 mmol, 1.1 eq) was added and stirred for 30 mins at - 40°C to -50°C. At the same temperature compound 1 (4.85 g, 59 mmol, 1 eq) in THF (20 mL) was added dropwise in 15 mins. Then the reaction mixture was warmed to room temperature in 1 hour and stirred for additional 1 hour to obtain a white suspension of the compound 2.
  • This suspension was filtrated over a paper filter (7 cm diameter) and washed with TBME (200 mL) to obtain filter cake containing the compound 2 (19.40 g, 67.1wt% purity, 97% yield).
  • the filter cake obtained according to Example 3 was loaded in a four necked round bottom flask under argon atmosphere. Butyl acetate (100 mL) was added and acetic acid (7.75 g, 129 mmol, 1.0 eq) was added dropwise in 5 mins. The reaction mixture was stirred for 30 mins at room temperature and then filtered over a paper filter (7 cm diameter). The filtrate was dried at 45°C (2 mbar) to produce a colorless oil which crystallized slowly to obtain the compound 4 (13.22 g, 98.8wt% purity, 92% yield).
  • the filter cake obtained according to Example 3 was loaded in a four necked round bottom flask under argon atmosphere. Butyl acetate (50 mL) was added and H 2 0 (20 mL) was added dropwise in 5 mins. The reaction mixture was stirred for 10 mins at room temperature and then extracted with butyl acetate (50 mL x 3). The organic phase was dried at 45°C (2 mbar) to produce a colorless oil which crystallized slowly to obtain the compound 4 (7.0 g, 53% yield based on acetonitrile).

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention provides a substituted enamine compound of formula (I), and a process for producing oxazole compounds from the compound of formula (I). According to the processes of the present invention, it can produce substituted enamine compounds with high yield and selectivity while avoiding toxic or unsafe reagents for producing oxazole compounds. wherein R is H, lower alkyl or aryl, optionally substituted by one or more substituents.

Description

A process for preparation of substituted enamine compounds
Technical Field
The present invention is related to a new process for producing substituted enamine compounds.
Background of the Invention
Oxazole compounds represent a vast class of heterocyclic aromatic organic compounds. Oxazole compounds have become increasingly important because of biological activities and their use as intermediates for the preparation of new biological materials. The wide range of biological activities of oxazole compounds includes anti-inflammatory, analgesic, antibacterial, antifungal, hypoglycemic, antiproliferative, anti-tuberculosis, muscle relaxant and HIV inhibitor activity. In addition, oxazole derivatives are important intermediates for preparation of biological compounds such as vitamin B6.
Various processes for the preparation of oxazole compounds have been developed. One preferred process in industry is from alanine and oxalic acid in EtOH carried out by azeotropic distillation with benzene. Following this concept, the ring closure reaction to obtain 5-ethoxy-4-methyloxazole can also be carried out using phosgene or triphosgene, which is toxic and not environment friendly (see CN 104725262 B, CN 102898321 A and CN 105985297 A)
In recent years, one attractive process is direct cyclodehydration of acyloxy enamines because acyloxy enamines have been introduced early N-atom and installed the carboxylic acids. It was reported that acyloxy enamines can be synthesized by intermolecular oxidative coupling of an enamine compound with carboxylic acid by using iodosobenzene as the oxidant. However, oxidant iodosobenzene is highly flammable and has explosion risk. In addition, oxidant iodosobenzene is not soluble in solvents and thus results in unstable yields of the process (see Xin Liu et al., Org. Lett., Vol. 14, No. 21, 2012).
Therefore, there is still demand of a new process for the preparation of substituted enamines, which can be converted to oxazole compounds, in industry.
Summary of the Invention The present invention provides a substituted enamine compound of formula (I), which can be converted to an oxazole compound,
Figure imgf000003_0001
wherein R is H, lower alkyl or aryl, optionally substituted by one or more substituents.
The present invention also provides a process for producing the compound of formula (I) and a process for producing oxazole compounds from the compound of formula (I).
According to the processes of the present invention, it can produce substituted enamine compounds with high yield and selectivity, while avoiding toxic or unsafe reagents for producing oxazole compounds.
Detailed Description of the Invention
In the present invention, the term "lower alkyl" as used refers to Ci-Cio alkyl, i.e., branched or unbranched, cyclic or non-cyclic, saturated hydrocarbon comprising 1-10 carbon atoms. Preferably, the "lower alkyl" is Ci-C6 alkyl, including but not limited to methyl, ethyl, propyl, isopropyl, cyclopropyl, butyl, isobutyl, tert- butyl, cyclobutyl, pentyl, iso-pentyl, tert-pentyl, cyclopentyl, hexyl, isohexyl, tert-hexyl, cyclohexyl, octyl, isooctyl, tert-octyl, cyclooctyl, nonyl, isononyl, tert-nonyl, cyclononyl, decyl, isodecyl, tert-decyl, cyclodecyl. More preferably, the "lower alkyl" is methyl or ethyl.
In the present invention, the term "aryl" as used refers to aromatic hydrocarbon such as phenyl, benzyl, xylyl and naphthalenyl.
In the present invention, the term "lower alkoxyl" as used refers to the structure represented by (lower alkyl)-0-, wherein the lower alkyl is defined as above.
In the present invention, the term "carbonyl group" as used refers to the structure represented by -(C=0)-. In the present invention, the term "halo" or "halogen" as used refers to a group of elements including fluorine (F), chlorine (Cl), bromine (Br) and iodine (I), preferably refers to Cl or Br.
In the present invention, the term "substituents" as used refers to lower alkyl, lower alkoxyl, hydroxyl, halo, -NH2, -N02, cyano or isocyano.
In the first aspect of the present invention, it provides a process for producing a compound of formula (I), comprising: a) reacting a compound of formula (II) with a compound of formula (III) to produce a compound of formula (la); and
Figure imgf000004_0002
b) converting the compound of formula (la) into the compound of formula (I),
Figure imgf000004_0001
(la) (I) wherein
R is H, lower alkyl or aryl, optionally substituted by one or more substituents; and
R' is H; and any two of Ri, R2 and R3, together with the carbon they connect, form a carbonyl group, and the rest one is hydroxyl, lower alkyl, lower alkoxyl, aryl, or NR4R4' (wherein R4 and R4' are dependently H or lower alkyl), optionally substituted by one or more substituents; or R', Ri, R2 and R3, together with the carbon they connect, form carbon monoxide (Cº0).
Preferably, R is H or Ci-Ce alkyl, optionally substituted by one or more substituents. More preferably, R is H, methyl, ethyl, propyl or butyl, optionally substituted by one or more substituents. The most preferably, R is H or methyl.
Preferably, any two of Ri, R2 and R3, together with the carbon they connect, form a carbonyl group, and the rest one is hydroxyl, Ci-C6 lower alkyl, Ci-C6 lower alkoxyl, aryl, or NR4R4' (wherein R and R ' are dependently H or Ci-C6 lower alkyl), optionally substituted by one or more substituents. More preferably, the rest one is hydroxyl, methyl, ethyl, propyl, butyl, methoxyl, ethoxyl, propoxyl, butoxyl, or NR4R4' (wherein R and R ' are dependently H, methyl, ethyl, propyl or butyl), optionally substituted by one or more substituents. The most preferably, the rest one is hydroxyl, methoxyl, ethoxyl, or NR4R4' (wherein R and R ' are dependently H, methyl or ethyl), optionally substituted by one or more substituents.
More preferably, R', Ri, R2 and R3, together with the carbon they connect, form carbon monoxide (Cº0).
In one embodiment,
R is H, methyl, ethyl or phenyl; and any two of Ri, R2 and R3, together with the carbon they connect, form a carbonyl group, and the rest one is hydroxyl, methoxyl, ethoxyl, or NR4R4' (wherein R and R ' are dependently H, methyl or ethyl).
In another embodiment,
R is H, methyl, ethyl or phenyl; and
The compound of formula (III) is carbon monoxide.
In one preferable embodiment,
R is H or methyl; and any two of Ri, R2 and R3, together with the carbon they connect, form a carbonyl group, and the rest one is hydroxyl, methoxyl, ethoxyl, -NH2 or -NHCH3.
In the present invention, the compound of formula (la) and (II) may be in a form of any salt of formula (la') and (IG) respectively:
Figure imgf000005_0001
(la ) (II·) wherein R is defined as above, and X and Y are dependently a metal element such as alkali metal elements (lithium (Li), sodium (Na), postassium (K), rubidium (Rb), caesium (Cs) and francium (Fr)); or alkaline-earth metal elements (beryllium (Be), magnesium (Mg), calcium (Ca), strontium (Sr), barium (Ba) and radium (Ra)); and Iron (ll/lll), nickel and cobalt. Preferably, X is Na or K.
In the step a) of the process of the present invention, the compound of formula (III) may be added in an amount of from 0.01 moles to 20 moles, preferably from 0.05 moles to 15 moles, more preferably from 0.1 mole to 10 moles, per 1 mole of the compound of formula (II).
The step a) of the process of the present invention may be carried out in the presence of a solvent. The solvent preferably is a polar organic solvent such as toluene, tetrahydrofuran (THF), methyl tert-butyl ether (TBME), alcohol (i.e., ethanol) and benzene, or mixture thereof.
The reaction of the step a) of the present invention may be carried out at the temperature from -30°C to 110°C, preferably from -20°C to 100°C, more preferably from -10°C to 50°C such as -10, -5, 0, 10, 15, 20, 25, 30, 35, 40, 45 and 50°C. After the reaction finishes, the obtained compound of formula (la) may be used to the next step b) directly or purified by known process such as crystallization and/or filtration.
In the step b) of the process of the present application, the compound of formula (la) may be converted into the compound of formula (I) by any suitable way, for example, by adding water, an acid, an acidic salt or an alcohol. The Examples of the acid include but are not limited to organic acid such as formic acid, acetic acid, propionic acid, butyric acid, oxalic acid, citric acid, lactic acid, malic acid, succinic acid, tartaric acid, fumaric acid and maleic acid; inorganic acid such as hydrochloric acid, sulfonic acid, phosphoric acid, nitric acid, nitrous acid, chloric acid, hypochlorous acid, perchloric acid, sulfonic acid, hydrobromic acid and hydrofluoric acid; and acidic resin such as sulfonic acid resin. The examples of the acidic salt include but are not limited to ammonium chloride, monopotassium phosphate, monosodium phosphate, sodium hydrogen sulfate and potassium hydrogen sulfate. The examples of the alcohol include but are not limited to methanol, ethanol and phenol.
In one embodiment, the compound of formula (la) is converted into the desired compound of formula (I) by adding an acid as defined above. The acid may be added in an amount of from 0.1 mol to 10 mol, preferably from 0.5 mol to 8 mol, more preferably from 1 mol to 5 mol such as 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5 and 10 mol, per 1 mol of the compound of formula (la). In an alternative embodiment, the compound of formula (la) is converted into the desired compound of formula (I) by adding water. The water may be added in an amount of from 10 mL to 1000 mL, preferably from 18 mL to 500 mL, more preferably from 20 mL to 100 mL, per 1 mol of the compound of formula (la).
In the step b) of the process of the present application, a solvent may be used when necessary. Example of the suitable solvent include but are not limited to ethyl acetate, ethyl butyrate, butyl acetate, tetrahydrofuran, toluene, 1,4-dioxane, 2,5-dimethyltetrahydrofuran, methyl tetrahydrofuran, dimethyl ether, diethyl ether, acetonitrile, methyl tert-butyl ether, and mixture thereof.
The step b) of the process of the present invention may be carried out at the temperature from 0°C to 50°C, preferably from 10°C to 40°C, such as 10, 15, 20, 25, 30, 35 and 40°C. After the reaction finishes, the obtained compound of formula (I) may be directly used for industrial application, or purified by known process such as extraction, crystallization and/or filtration.
In the process of the present application, the reaction mixture of the step a) containing the compound of formula (la) is preferably used to the step b) directly without isolation and purification. In such case, the process of the present application may be carried out in one pot.
Accordingly, the present invention also provides a one-pot process for the preparation of the compound of formula (I), which comprises adding the compound of formula (II) as defined above, the compound of formula (III) as defined above, optionally the solvent as defined above, and water or an acid or an acidic salt or an alcohol as defined above into one pot for reaction to obtain the compound of formula (I).
The compound of formula (II) may be prepared by any process known in the art in-situ or ex-situ, for example, by treating the compound of formula (lla) with a strong base such as sodium (Na), Sodium hydride (NaH) or sodium amide.
Figure imgf000007_0001
Wherein Ri is as defined above.
Alternatively, the compounnd of formula (II) may be produced from nitriles as disclosed in US 5187297 A. The processes of the present invention avoid toxic and unsafe reagents while providing high yield and high selectivity. In addition, the obtained products of the processes of the present invention can be used for producing oxazole compounds directly without any purification.
In the second aspect of the present invention, it provides a process for producing an oxazole compound comprising the step for producing the compound of formula (la) and/or the compound of formula (I) as described above. The process of the present invention avoids toxic phosphate reagents and saves steps compared to the processes known in the art and thus provides a new process.
The present invention will be further illustrated by the following examples.
Examples
Example 1
Figure imgf000008_0001
1 2
A dried four necked round bottom flask was charged with liquid ammonia (15 mL, 0.615 mol, 11 eq). After the flask was flushed with argon, sodium (1.5 g, 65 mmol, 1.1 eq) was added and stirred for 30 mins at - 40°C to -50°C. At the same temperature compound 1 (4.85 g, 59 mmol, 1 eq) in THF (20 mL) was added dropwise in 15 mins. Then the reaction mixture was warmed to room temperature in 1 hour and stirred for additional 1 hour to obtain a white suspension of the compound 2.
1H NMR of f/Z-isomers of compound 2 (400 MHz, DMSO) d (ppm): 1.74 (3H) (46.7%), 1.53 (3H) (53.3%).
Example 2
Figure imgf000008_0002
2 A dried four necked round bottom flask was charged with liquid ammonia (50 mL, 2.05 mol, 16 eq). After the flask was flushed with argon, iron nitrate nonahydrate (35 mg, 0.087 mmol, 0.00067 eq) was added. Then sodium (2.96 g, 129 mmol, 1.0 eq) was added and stirred for 30 mins at -40°C to -50°C. At the same temperature anhydrous acetonitrile (11.65 g, 283 mmol, 2.2 eq) was added dropwise in 15 mins and anhydrous toluene (40 mL) was added immediately. The reaction mixture was warmed to room temperature in 1 hour and stirred for additional 1 hour to obtain a grey suspension.
This suspension was filtrated over a paper filter (7 cm diameter) and washed with TBME (200 mL) to obtain filter cake containing the compound 2 (19.40 g, 67.1wt% purity, 97% yield).
Example 3
Figure imgf000009_0001
Ethyl formate (10.71 g, 142 mmol, 1.1 eq) dissolved in anhydrous toluene (20 mL) was added dropwise to the grey suspension (13.43 g, 129 mmol, 1.0 eq) obtained according to the same procedures of Example 2 in 20 mins. The reaction mixture was stirred overnight to obtain a grey and thick suspension. TBME (100 mL) was added and the mixture was filtrated over a paper filter (7 cm diameter) to obtain a filter cake containing compound 3 (49.68 g, 31.6wt% purity, 92% yield).
NMR of E -isomer of compound 3 (400 MHz, DMSO) d (ppm): 8.81 (1H), 3.73 (1H), 1.82 (1H).
NMR of Z-isomer of compound 3 (400 MHz, DMSO) d (ppm): 8.58 (1H), 4.21 (1H), 1.93 (3H).
Example 4
Figure imgf000009_0002
Ethyl formate (4.82 g, 65 mmol, 0.5 eq) dissolved in THF (10 mL) was added dropwise to the grey suspension (13.43 g, 129 mmol, 1.0 eq) according to the same procedures of Example 2 except that toluene was replaced with THF in 20 mins. The reaction mixture was stirred overnight to obtain a grey and thick suspension. TBME (100 mL) was added and the mixture was filtrated over a paper filter (7 cm diameter) to obtain a filter cake containing compound 3 (7.40 g, 82% yield).
Example 5
Figure imgf000010_0001
Methyl formate (9.28 g, 155 mmol, 1.2 eq) dissolved in TBME (20 mL) was added dropwise to the grey suspension (13.43 g, 129 mmol, 1.0 eq) obtained according to the same procedures of Example 2 except that toluene was replaced with TBME in 30 min. The reaction mixture was stirred over night to obtain a white and thick suspension. TBME (100 mL) was added. Then, the mixture was filtrated over a paper filter (7 cm diameter) to obtain a filter cake containing compound 3 (15.19 g, 89% yield).
Example 6
Figure imgf000010_0002
2 3
Dimethyl formamide (6.95 g, 95 mmol, 3 eq) dissolved in toluene (5 mL) was added dropwise to the grey suspension (3.3 g, 31.7 mmol, 1.0 eq) obtained according to the same procedures of Example 2 in 10 min. The reaction mixture was stirred for 3 days at 40°Cto obtain a white suspension. TBME (50 mL) was added. Then, the mixture was filtrated over a paper filter (4 cm diameter) to obtain a filter cake containing compound 3 (1.98 g, 47% yield).
Example 7
Figure imgf000010_0003
2 3 Carbon monoxide (50 bar overpressure) was added to ethanol (10 mL) and the filter cake (347 mg, 3.33 mmol, 1.0 eq) obtained according to the same procedures of Example 2. The reaction mixture was shaked over 19 h at 70°C to obtain a yellow suspension. TBME (20 mL) was added. Then, the mixture was filtrated over a paper filter (2 cm diameter) to obtain a filter cake containing compound 3 (248 mg, 56% yield).
Example 8
Figure imgf000011_0001
3 4
The filter cake obtained according to Example 3 was loaded in a four necked round bottom flask under argon atmosphere. Butyl acetate (100 mL) was added and acetic acid (7.75 g, 129 mmol, 1.0 eq) was added dropwise in 5 mins. The reaction mixture was stirred for 30 mins at room temperature and then filtered over a paper filter (7 cm diameter). The filtrate was dried at 45°C (2 mbar) to produce a colorless oil which crystallized slowly to obtain the compound 4 (13.22 g, 98.8wt% purity, 92% yield).
NMR of Z-isomer of compound 4 (400 MHz, DMSO) d (ppm): 10.20 (1H), 8.43 (1H), 4.90 (1H), 2.15 (3H). H NMR of f-isomer of compound 4 (400 MHz, DMSO) d (ppm): 10.40 (1H), 8.81 - 8.14 (1H), 6.37 - 4.78 (1H), 2.39 -1.97 (3H).
Example 9
Figure imgf000011_0002
3 4
The filter cake obtained according to Example 3 was loaded in a four necked round bottom flask under argon atmosphere. Butyl acetate (50 mL) was added and H20 (20 mL) was added dropwise in 5 mins. The reaction mixture was stirred for 10 mins at room temperature and then extracted with butyl acetate (50 mL x 3). The organic phase was dried at 45°C (2 mbar) to produce a colorless oil which crystallized slowly to obtain the compound 4 (7.0 g, 53% yield based on acetonitrile).
Example 10
Figure imgf000012_0001
1 4
A dried round bottom flask was charged with THF (250 mL). After the flask was flushed with argon, NaH (40 g, 1000 mmol, 2 eq) was added. Then the mixture of compound 1 (41.1 g, 500 mmol, 1 eq) and ethyl formate (71.4 g, 1000 mmol, 2 eq) in THF (250 mL) was added dropwise in 30 min and stirred at room temperature for 5 hours. Acetic acid (60.1 g, 1000 mmol, 2 eq) was added dropwise in 5 mins. The reaction mixture was stirred for 30 mins at room temperature and then filtered over a paper filter (7 cm diameter). The filtrate was dried at 45°C (2 mbar) to produce a colorless oil which crystallized slowly to obtain the compound 4 (45.2 g, 82% yield).
Example 11
Figure imgf000012_0002
4 5
To a solution of the compound 4 (220 mg, 2.0 mmol) in dried 1,2-dichloroethane (20 mL) was added BF3-Et20 (4.0 mmol, 2.0 eq). The reaction mixture was heated to reflux, and then phenyliodine(lll) diacetate (838 mg, 2.6 mmol, 1.3 eq) was added in one portion rapidly. After stirring under refluxing condition for 0.5-3 hours, the reaction mixture was cooled down to room temperature, quenched with saturated aqueous NaHC03, and then extracted with dichloromethane. The combined organic layer was washed with brine, dried over anhydrous l\la2SC>4 and concentrated by the rotary evaporator. The crude product was purified by flash column chromatography to give the compound 5 (140 mg, 65% yield).

Claims

Claims
1. A process for producing a compound of formula (I), comprising: a) reacting a compound of formula (II) with a compound of formula (III) to produce a compound of formula (la); and
Figure imgf000013_0002
b) converting the compound of formula (la) into the compound of formula (I),
Figure imgf000013_0001
wherein
R is H, lower alkyl or aryl, optionally substituted by one or more substituents; and
R' is H; and any two of Ri, R2 and R3, together with the carbon they connect, form a carbonyl group, and the rest one is hydroxyl, lower alkyl, lower alkoxyl, aryl, or NR R ' (wherein R and R ' are dependently H or lower alkyl), optionally substituted by one or more substituents; or R', Ri, R2 and R3, together with the carbon they connect, form carbon monoxide (Cº0).
2. The process of claim 1, wherein R is H, methyl, ethyl, propyl or butyl, optionally substituted by one or more substituents.
3. The process of claim 1, wherein any two of Ri, R2 and R3, together with the carbon they connect, form a carbonyl group, and the rest one is hydroxyl, methyl, ethyl, propyl, butyl, methoxyl, ethoxyl, propoxyl, butoxyl, or NR R ' (wherein R and R ' are dependently H, methyl, ethyl, propyl or butyl), optionally substituted by one or more substituents.
4. The process of claim 1, wherein R', Ri, R2 and R3, together with the carbon they connect, form carbon monoxide (Cº0).
5. The process of claim 1, wherein R is H, methyl, ethyl or phenyl; and any two of Ri, R2 and R3, together with the carbon they connect, form a carbonyl group, and the rest one is hydroxyl, methoxyl, ethoxyl, or NR4R4' (wherein R and R ' are dependently H, methyl or ethyl).
6. The process of claim 1, wherein R is H, methyl, ethyl or phenyl; and the compound of formula (III) is carbon monoxide.
7. The process of claim 1, wherein R is H or methyl; and any two of Ri, R2 and R3, together with the carbon they connect, form a carbonyl group, and the rest one is hydroxyl, methoxyl, ethoxyl, -NH2 or -NHCH3.
8. The process of claim 1, wherein the compound of formula (la) and (II) are in a form of any salt of formula (la') and (IG) respectively:
Figure imgf000014_0001
(la ) (II·) wherein R is defined as any one of claims 1-7, and X and Y are dependently a metal element such as alkali metal elements (lithium (Li), sodium (Na), postassium (K), rubidium (Rb), caesium (Cs) and francium (Fr)); or alkaline-earth metal elements (beryllium (Be), magnesium (Mg), calcium (Ca), strontium (Sr), barium (Ba) and radium (Ra)); and Iron (ll/lll), nickel and cobalt.
9. The process of any one of claims 1-8, wherein the step a) of the process is carried out in the presence of a solvent.
10. The process of claim 9, wherein the solvent is a polar organic solvent such as toluene, tetrahydrofuran (THF), methyl tert-butyl ether (TBME), alcohol (i.e., ethanol) and benzene, or mixture thereof.
11. The process of any one of claims 1-8, wherein in the step b) the compound of formula (la) is converted into the compound of formula (I) by adding water, an acid, an acidic salt or an alcohol.
12. The process of any one of claims 1-8, wherein in the step b) the compound of formula (la) is converted into the compound of formula (I) by adding an acid selected from the group consisting of organic acid such as formic acid, acetic acid, propionic acid, butyric acid, oxalic acid, citric acid, lactic acid, malic acid, succinic acid, tartaric acid, fumaric acid and maleic acid; inorganic acid such as hydrochloric acid, sulfonic acid, phosphoric acid, nitric acid, nitrous acid, chloric acid, hypochlorous acid, perchloric acid, sulfonic acid, hydrobromic acid and hydrofluoric acid; and acidic resin such as sulfonic acid resin.
13. The process of any one of claims 1-8, wherein in the step b) a solvent is used.
14. The process of claim 13, wherein the solvent is selected from the group consisting of ethyl acetate, ethyl butyrate, butyl acetate, tetrahydrofuran, toluene, 1,4-dioxane, 2,5-dimethyltetrahydrofuran, methyl tetrahydrofuran, dimethyl ether, diethyl ether, acetonitrile, methyl tert-butyl ether, and mixture thereof.
15. The process of any one of claims 1-8, wherein the process is carried out in one pot.
16. The process of any one of claims 1-8, wherein the compound of formula (II) is prepared in-situ.
17. A process for producing an oxazole compound comprising the step for producing the compound of formula (la) and/or the compound of formula (I) according to any one of claims 1-16.
18. A compound of formula (I) or a salt thereof,
Figure imgf000015_0001
wherein R is H, lower alkyl or aryl, optionally substituted by one or more substituents.
19. The compound of claim 18, wherein R is H, methyl, ethyl, propyl or butyl, optionally substituted by one or more substituents.
20. The compound of claim 18 or 19, wherein the salt is a compound of formula (la')
Figure imgf000016_0001
wherein R is defined as claims 18 or 19, and X is a metal element such as alkali metal elements (lithium (Li), sodium (Na), postassium (K), rubidium (Rb), caesium (Cs) and francium (Fr)); or alkaline-earth metal elements (beryllium (Be), magnesium (Mg), calcium (Ca), strontium (Sr), barium (Ba) and radium (Ra)); and Iron (ll/lll), nickel and cobalt.
PCT/EP2021/058580 2020-04-17 2021-04-01 A process for preparation of substituted enamine compounds WO2021209269A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP21717374.9A EP4136066A1 (en) 2020-04-17 2021-04-01 A process for preparation of substituted enamine compounds
CN202180027529.0A CN115397807B (en) 2020-04-17 2021-04-01 Process for preparing substituted enamine compounds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2020085419 2020-04-17
CNPCT/CN2020/085419 2020-04-17

Publications (1)

Publication Number Publication Date
WO2021209269A1 true WO2021209269A1 (en) 2021-10-21

Family

ID=75438752

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2021/058580 WO2021209269A1 (en) 2020-04-17 2021-04-01 A process for preparation of substituted enamine compounds

Country Status (3)

Country Link
EP (1) EP4136066A1 (en)
CN (1) CN115397807B (en)
WO (1) WO2021209269A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022218733A1 (en) * 2021-04-15 2022-10-20 Dsm Ip Assets B.V. A process for preparation of substituted enamine compounds
WO2022218734A1 (en) * 2021-04-15 2022-10-20 Dsm Ip Assets B.V. A process for preparation of substituted enamine compounds

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5187297A (en) 1990-11-05 1993-02-16 Lonza Ltd. Process for the production of 3-aminocrotononitrile
WO2007112317A1 (en) * 2006-03-24 2007-10-04 University Of Notre Dame Du Lac Method and apparatus for prediction of enantiomeric excess
CN102898321A (en) 2011-07-24 2013-01-30 上海海嘉诺医药发展股份有限公司 Method for preparing N-butoxy oxalyl butyl alaninate
CN104725262A (en) 2013-12-23 2015-06-24 大丰海嘉诺药业有限公司 Method for continuously preparing N-ethyloxyl oxalyl alanine ethyl ester
CN105985297A (en) 2015-01-30 2016-10-05 湖北得正医药科技有限公司 Synthesis technology of vitamin B6 intermediate 4-methyl-5-ethyoxyl-2-oxazole acid ethyl

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS509775B2 (en) * 1972-11-07 1975-04-16
CA1136132A (en) * 1975-02-17 1982-11-23 Teruji Tsuji Cyclization to form cephem ring and intermediates therefor
EP0831091A3 (en) * 1996-09-23 1998-04-15 Novartis AG Process for the production of 3-aryl-uracils
GB0605766D0 (en) * 2006-03-22 2006-05-03 Ucb Sa Process
AP2013006953A0 (en) * 2010-12-07 2013-06-30 Bayer Ip Gmbh Substituted 1-benzylcycloalkylcarboxlic acids and use thereof
EP3138856B1 (en) * 2014-04-29 2020-11-04 China Petroleum&Chemical Corporation Method for preparation of a catalyst component used for olefin polymerization
JOP20190278A1 (en) * 2017-05-31 2019-11-28 Novartis Ag 5,6-fused-bicyclic compounds and compositions for the treatment of parasitic diseases

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5187297A (en) 1990-11-05 1993-02-16 Lonza Ltd. Process for the production of 3-aminocrotononitrile
WO2007112317A1 (en) * 2006-03-24 2007-10-04 University Of Notre Dame Du Lac Method and apparatus for prediction of enantiomeric excess
CN102898321A (en) 2011-07-24 2013-01-30 上海海嘉诺医药发展股份有限公司 Method for preparing N-butoxy oxalyl butyl alaninate
CN104725262A (en) 2013-12-23 2015-06-24 大丰海嘉诺药业有限公司 Method for continuously preparing N-ethyloxyl oxalyl alanine ethyl ester
CN105985297A (en) 2015-01-30 2016-10-05 湖北得正医药科技有限公司 Synthesis technology of vitamin B6 intermediate 4-methyl-5-ethyoxyl-2-oxazole acid ethyl

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BENARY ERICH ET AL: "Über einige Säurederivate von Dinitrilen und [beta]-Amino-crotonsäure-ester", BERICHTE DER DEUTSCHEN CHEMISCHEN GESELLSCHAFT ABTEILUNG B:ABHANDLUNGEN, vol. 55, no. 10, 11 November 1922 (1922-11-11), DE, pages 3417 - 3429, XP055816507, ISSN: 0365-9488, Retrieved from the Internet <URL:https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcber.19220551009> DOI: 10.1002/cber.19220551009 *
FELDGUS STEVEN ET AL: "Origin of Enantioreversal in the Rhodium-Catalyzed Asymmetric Hydrogenation of Prochiral Enamides and the Effect of the [alpha]-Substituent", ORGANOMETALLICS, vol. 20, no. 11, 1 May 2001 (2001-05-01), pages 2374 - 2386, XP055816485, ISSN: 0276-7333, DOI: 10.1021/om010060t *
MEYER E V: "Untersuchungen aus dem organ.-chem. Laboratorium der Technicschne Hochschule zu Dresden: CVI. Neue Beiträge zur Kenntnis der di-molekulären Nitrile", vol. 90, no. 1, 12 June 1914 (1914-06-12), pages 1 - 52, XP009035294, ISSN: 0021-8383, Retrieved from the Internet <URL:https://gallica.bnf.fr/ark:/12148/bpt6k90862k/f61.item> [retrieved on 20041119], DOI: 10.1002/PRAC.19140900101 *
XIN LIU ET AL., ORG. LETT., vol. 14, no. 21, 2012

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022218733A1 (en) * 2021-04-15 2022-10-20 Dsm Ip Assets B.V. A process for preparation of substituted enamine compounds
WO2022218734A1 (en) * 2021-04-15 2022-10-20 Dsm Ip Assets B.V. A process for preparation of substituted enamine compounds

Also Published As

Publication number Publication date
CN115397807A (en) 2022-11-25
EP4136066A1 (en) 2023-02-22
CN115397807B (en) 2024-08-13

Similar Documents

Publication Publication Date Title
US6156925A (en) Process for the preparation of halogenated phenylmaloates
WO2021209269A1 (en) A process for preparation of substituted enamine compounds
CN106164052A (en) For the method preparing grace miscellaneous Shandong amine
JP4039693B2 (en) A new process for preparing pesticide intermediates
US7355065B2 (en) Process for the preparation of 4,4-difluoro-3-oxobutanoic acid esters
US6187926B1 (en) Process for producing quinolone derivatives
WO2022218734A1 (en) A process for preparation of substituted enamine compounds
WO2022218733A1 (en) A process for preparation of substituted enamine compounds
JP2015521635A (en) Method for preparing solifenacin or a salt thereof
JP4138067B2 (en) Method for producing methine derivative
WO2003014067A1 (en) PROCESS FOR PRODUCING ß-OXONITRILE COMPOUND OR ALKALI METAL SALT THEREOF
JP4032861B2 (en) Process for producing β-oxonitrile derivative or alkali metal salt thereof
JPH02289563A (en) Improved process for producing ortho-carboxypyridyl- and ortho-carboxyquinolylimidazolinones
KR19990008411A (en) Improvement method of 4-hydroxy-2-pyrrolidone
JP7474754B2 (en) Novel process for producing diaminopyrimidine derivatives or acid addition salts thereof
JP5205971B2 (en) Method for producing tetrahydropyran compound
JPH07291933A (en) Production of 2,5-disubstituted pyridine
US20030171578A1 (en) Pyrrolidinone derivative compound
JP3855686B2 (en) 3,3-dialkoxy-2-hydroxyimino derivative and process for producing the same
JP4561635B2 (en) Process for producing 4-alkoxycarbonyltetrahydropyran or tetrahydropyranyl-4-carboxylic acid
JP4165110B2 (en) Preparation of 4-oxypyrimidine derivatives
JP6742316B2 (en) Novel process for the preparation of spiro[2.5]octane-5,7-dione and spiro[3.5]nonane-6,8-dione
JP4449211B2 (en) 6- (1-fluoroethyl) -5-iodo-4-pyrimidone and process for producing the same
KR101200294B1 (en) Process for the preparation of 4,4-difluoro-3-oxobutanoic acid esters
JP2021161097A (en) Novel crystal form of teneligliptin and method for producing the same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21717374

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 202217048519

Country of ref document: IN

ENP Entry into the national phase

Ref document number: 2021717374

Country of ref document: EP

Effective date: 20221117

NENP Non-entry into the national phase

Ref country code: DE